AI assistant
JOHNSON & JOHNSON — Director's Dealing 2024
Feb 13, 2024
29750_dirs_2024-02-12_3ef6637a-69af-4302-be8a-f2b1234b87d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-08
Reporting Person: Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-08 | Common Stock | M | 3739.0000 | $0.0000 | Acquired | 143329.0010 | Direct |
| 2024-02-08 | Common Stock | F | 1913.0000 | $156.3300 | Disposed | 141416.0010 | Direct |
| 2024-02-09 | Common Stock | M | 59397.0000 | $90.4400 | Acquired | 200813.0010 | Direct |
| 2024-02-09 | Common Stock | S | 59397.0000 | $156.2700 | Disposed | 141416.0010 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | Restricted Share Units | $ | M | 3739.0000 | Disposed | Common Stock (3739.0000) | Direct | |
| 2024-02-09 | Employee Stock Options (Right to Buy) | $90.4400 | M | 59397.0000 | Disposed | 2024-02-09 | Common Stock (59397.0000) | Direct |
Footnotes
F1: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3: This transaction was executed in multiple trades at prices ranging from $156.180 to $156.360. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.